GL1X · GenesisL1 explorer

MolNFT v1 · #32734 · protein

Orally available FACTOR7A inhibitor

2BZ6 · Blood coagulation factor viia: “Orally available FACTOR7A inhibitor”. X-ray diffraction, 3 ligands (346, CA, SO4), 3 pockets (best druggability 0.49). MolNFT v1 #32734 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
2BZ6
Type
protein
Length
307 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Blood coagulation factor viia
EC
3.4.21.21
UniProt
P08709
Ligands
346, CA, SO4
Pockets
3 · best druggability 0.49

Structure

x-ray diffraction · 2 distinct chains · 14% helix, 36% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
HBlood coagulation factor viia (EC 3.4.21.21)protein25415% helix, 37% strandP08709
LBlood coagulation factor viia (EC 3.4.21.21)protein538% helix, 30% strandP08709

Ligands and binding sites

  • 346 · (R)-(4-carbamimidoyl-phenylamino)-[5-ethoxy-2-fluoro-3-[(R)-tetrahydro-furan-3-yloxy]-phenyl]-acetic acid · ligand · chains H
  • CA · Calcium ion · metal · chains H
  • SO4 · Sulfate ion · ion · chains H

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1790.490.8317empty
21490.420.7422empty
3950.380.7623346

Interfaces

1 interface between chains.

  • H–L · 1030 Ų buried · 10 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 8 disulfide (disulfide).

Compared structures

  • 2BZ6 · Orally available Factor7a inhibitor · the same entry in another collection · chain H against H, TM-score 1.00
  • P08709 · AlphaFold monomer V2.0 prediction for coagulation factor VII (P08709) · a predicted model of the same protein · chain H against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.